CKD awareness and blood pressure control in the primary care hypertensive population
- PMID: 21087817
- DOI: 10.1053/j.ajkd.2010.08.022
CKD awareness and blood pressure control in the primary care hypertensive population
Abstract
Background: Chronic kidney disease (CKD) is associated with poor renal and cardiovascular outcomes, and early identification largely depends on general practitioners' (GPs') awareness of it. To date, no study has evaluated CKD prevalence in patients with hypertension in primary care.
Study design: Cross-sectional evaluation of the Italian GPs' database.
Setting & participants: 39,525 patients with hypertension representative of the Italian hypertensive population followed up by GPs in 2005.
Factor: Estimated glomerular filtration rate (eGFR); eGFR <60 mL/min/1.73 m² was defined as CKD.
Outcomes: GPs' awareness of CKD assessed using International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes for CKD, and blood pressure (BP) control.
Measurements: Data concerning serum creatinine levels, BPs, and antihypertensive medications were obtained for each patient from the GPs' database; eGFR was calculated according to the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation.
Results: CKD prevalence was 23%, but kidney disease was diagnosed by GPs in only 3.9% of patients. BP control was inadequate in patients with CKD and those with eGFR >60 mL/min/1.73 m², with only 44% of patients reaching a BP target <140/90 mm Hg and 11% achieving <130/80 mm Hg. Patients with eGFR <60 mL/min/1.73 m² whose GPs were aware of CKD were more likely to reach recommended BP target values (OR, 1.35; 95% CI, 1.15-1.59; P < 0.001).
Limitations: The prevalence of decreased eGFR may be overestimated because of the lack of creatinine calibration. Proteinuria data were not available.
Conclusions: Awareness of CKD by GPs is critical for achieving the recommended guideline BP targets. However, awareness of CKD by GPs is still far too low, highlighting the need to systematically adopt eGFR for more accurate identification of CKD in high-risk populations.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10. Nephrol Dial Transplant. 2009. PMID: 19073656
-
Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.Am J Kidney Dis. 2008 Sep;52(3):444-53. doi: 10.1053/j.ajkd.2008.03.002. Epub 2008 May 12. Am J Kidney Dis. 2008. PMID: 18468747
-
Comparison of the MDRD Study and the CKD-EPI Study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study.Nephrol Dial Transplant. 2012 Aug;27(8):3210-7. doi: 10.1093/ndt/gfs047. Epub 2012 Apr 6. Nephrol Dial Transplant. 2012. PMID: 22492828
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
-
Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.Am J Nephrol. 2012;36(1):1-10. doi: 10.1159/000339327. Epub 2012 Jun 13. Am J Nephrol. 2012. PMID: 22699366 Review.
Cited by
-
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community.Clin Kidney J. 2020 Dec 22;14(1):23-35. doi: 10.1093/ckj/sfaa218. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33570513 Free PMC article. Review.
-
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.Nephrol Dial Transplant. 2023 Feb 28;38(3):532-541. doi: 10.1093/ndt/gfac283. Nephrol Dial Transplant. 2023. PMID: 36264305 Free PMC article.
-
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study.BMJ Open. 2023 May 22;13(5):e067386. doi: 10.1136/bmjopen-2022-067386. BMJ Open. 2023. PMID: 37217263 Free PMC article.
-
Kidney Disease Cohort (KidDiCo) of Southern Denmark: Design, Coverage, Generalizability and Implications for Use.Clin Epidemiol. 2021 Oct 14;13:971-980. doi: 10.2147/CLEP.S328512. eCollection 2021. Clin Epidemiol. 2021. PMID: 34703319 Free PMC article.
-
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?J Nephrol. 2022 Jul;35(6):1605-1618. doi: 10.1007/s40620-022-01336-7. Epub 2022 May 18. J Nephrol. 2022. PMID: 35583597 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous